KHEMLA, S.; MEESING, A.; SRIBENJALUX, W.; CHETCHOTISAKD, P. Lipid profiles of people with human immunodeficiency virus with dyslipidemia after switching from efavirenz to dolutegravir. Drug Target Insights, [S. l.], v. 17, n. 1, p. 45–53, 2023. DOI: 10.33393/dti.2023.2529. Disponível em: https://journals.aboutscience.eu/index.php/dti/article/view/2529. Acesso em: 23 nov. 2024.